MA39203A1 - Typage de hla à haute résolution - Google Patents

Typage de hla à haute résolution

Info

Publication number
MA39203A1
MA39203A1 MA39203A MA39203A MA39203A1 MA 39203 A1 MA39203 A1 MA 39203A1 MA 39203 A MA39203 A MA 39203A MA 39203 A MA39203 A MA 39203A MA 39203 A1 MA39203 A1 MA 39203A1
Authority
MA
Morocco
Prior art keywords
high resolution
hla typing
resolution hla
category
typing
Prior art date
Application number
MA39203A
Other languages
English (en)
Inventor
Mehdi Alizadeh
Gilbert Semana
Original Assignee
Francais Du Sang Ets
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Francais Du Sang Ets filed Critical Francais Du Sang Ets
Publication of MA39203A1 publication Critical patent/MA39203A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne des procédés et des kits améliorés de typage de locus de catégorie i et de catégorie ii d'antigène leukocytaire humain (hla) par amplification et séquençage d'adn.
MA39203A 2014-02-18 2015-02-17 Typage de hla à haute résolution MA39203A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14305226 2014-02-18
PCT/EP2015/053344 WO2015124583A1 (fr) 2014-02-18 2015-02-17 Typage de hla à haute résolution

Publications (1)

Publication Number Publication Date
MA39203A1 true MA39203A1 (fr) 2017-10-31

Family

ID=50231097

Family Applications (1)

Application Number Title Priority Date Filing Date
MA39203A MA39203A1 (fr) 2014-02-18 2015-02-17 Typage de hla à haute résolution

Country Status (9)

Country Link
US (1) US20170029886A1 (fr)
EP (1) EP3108005A1 (fr)
CN (1) CN106164287A (fr)
AU (1) AU2015220880A1 (fr)
CA (1) CA2937460A1 (fr)
CL (1) CL2016002030A1 (fr)
IL (1) IL246610A0 (fr)
MA (1) MA39203A1 (fr)
WO (1) WO2015124583A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107828889B (zh) * 2017-11-13 2021-06-11 首都医科大学附属北京儿童医院 一种用于hla-drb1*03基因定性检测的pcr扩增引物及试剂盒
CN108460246B (zh) * 2018-03-08 2022-02-22 北京希望组生物科技有限公司 一种基于三代测序平台的hla基因分型方法
HU231285B1 (hu) * 2018-04-18 2022-08-28 Printnet Kereskedelmi És Szolgáltató Kft. A miozin-2-izoformákat szelektíven gátló, gyógyászatilag hatásos vegyületek
WO2019229649A1 (fr) * 2018-05-29 2019-12-05 Gowda Malali Procédé de typage de super hla et kit associé
CN109371114A (zh) * 2018-12-26 2019-02-22 银丰基因科技有限公司 Hla-dqb1基因分型试剂盒
CN117512085B (zh) * 2023-11-21 2024-06-04 江苏伟禾生物科技有限公司 一种用于检测hla-dpb1基因分型的引物组及试剂盒

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5910413A (en) * 1997-10-10 1999-06-08 Visible Genetics, Inc. Method and kit for amplification, sequencing and typing of classical HLA class I genes
CN102124125A (zh) * 2007-10-16 2011-07-13 霍夫曼-拉罗奇有限公司 通过克隆性测序的高分辨率、高通量hla基因分型
CN103890190B (zh) * 2011-07-21 2016-08-17 吉诺戴夫制药株式会社 Hla基因的dna分型方法和试剂盒

Also Published As

Publication number Publication date
IL246610A0 (en) 2016-08-31
WO2015124583A1 (fr) 2015-08-27
AU2015220880A1 (en) 2016-07-21
EP3108005A1 (fr) 2016-12-28
CL2016002030A1 (es) 2017-08-04
CN106164287A (zh) 2016-11-23
US20170029886A1 (en) 2017-02-02
CA2937460A1 (fr) 2015-08-27

Similar Documents

Publication Publication Date Title
EA202090090A1 (ru) Включение неприродных нуклеотидов и способы с ними
IL283845A (en) Methods for detecting disease using analysis of rna
MX2020010974A (es) Composiciones y métodos para la edición de genes.
IL282290A (en) Methods for targeted insertion of dna in genes
EP3390668A4 (fr) Procédés de détermination du nombre de copies du gène tumoral par analyse d'adn acellulaire
CY1124929T1 (el) 4-οξο-3,4-διυδρο-1,2,3-βενζοτριαζινες ως ρυθμιστες του gpr139
MA39203A1 (fr) Typage de hla à haute résolution
EA201692157A1 (ru) Синтез двухцепочечных нуклеиновых кислот
BR112018016450A2 (pt) composições intensificadoras de vcn e métodos de uso das mesmas
EP3325665A4 (fr) Procédés d'amplification de séquences d'acides nucléiques
MA40576B1 (fr) Anticorps et immunoconjugués anti-her2
MX2021007011A (es) Receptores de antigenos quimericos de antigeno de maduracion de celulas b.
MA39248B1 (fr) Anticorps anti-jagged1 et procédés d'utilisation correspondants
EA202091673A1 (ru) Способ амплификации нуклеиновых кислот
MX2018011941A (es) Sistema de analisis de variantes geneticas y fenotipos y sus metodos de uso.
EA201992232A1 (ru) Композиции и способы для иммуноонкологии
MX380553B (es) Inhibidores macrocíclicos de las interacciones proteína/proteína de muerte programada 1 (pd-1)/pd-l1 y cd80(b7-1)/pd-l1.
MX387596B (es) Degradadores selectivos del receptor de estrógeno y sus usos.
MA40682B1 (fr) Anticorps anti-ox40 et procédés d'utilisation correspondants
MX379487B (es) Inmunomoduladores.
EA201891532A1 (ru) Композиции и способы лечения гемоглобинопатий
EA201891317A2 (ru) Терапевтические мишени для коррекции гена дистрофина человека с помощью редактирования генов и способы их применения
EP4467654A3 (fr) Fractionnement du génome
EA201792155A1 (ru) Композиции и способы детектирования биологического загрязнителя
CR20170240A (es) Anticuerpos anti-interleucina-33 y sus usos